Centers for Disease Control and Prevention (CDC), et al. Awareness of prediabetes--United States, 2005-2010. Morbidity and Mortality Weekly Report (MMWR). 2013;62(11):209.

Lily M, Godwin M. Treating prediabetes with metformin: systematic review and meta-analysis. Can Fam Physician. 2009;55(4):363–9.

PubMed  Google Scholar 

Wang N, Cheng J, Ning Z, Chen Y, Han B, Li Q, et al. Type 2 diabetes and adiposity induce different lipid profile disorders: a mendelian randomization analysis. J Clin Endocrinol Metab. 2018;103(5):2016–25.

Article  PubMed  Google Scholar 

Qujeq D, Mahrooz A, Alizadeh A, Masoumi P, Annemohammadzadeh S, Boorank R. Genotype and phenotype of salt-stimulated paraoxonase 1 (PON1) is associated with atherogenic indices in type 2 diabetes. J Diabetes Metab Disord. 2018;17(1):1–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liao JK. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibition beyond low-density lipoprotein cholesterol. Am J Cardiol. 2005;96(5):24–33.

Article  Google Scholar 

Chasman DI, Posada D, Subrahmanyan L, Cook NR, Stanton JVP, Ridker PM. Pharmacogenetic study of statin therapy and cholesterol reduction. JAMA. 2004;291(23):2821–7.

Article  CAS  PubMed  Google Scholar 

Glorioso N, Troffa C, Filigheddu F, Dettori F, Soro A, Parpaglia PP, et al. Effect of the HMG-CoA reductase inhibitors on blood pressure in patients with essential hypertension and primary hypercholesterolemia. Hypertension. 1999;34(6):1281–6.

Article  CAS  PubMed  Google Scholar 

Blum A, Shamburek R. The pleiotropic effects of statins on endothelial function, vascular inflammation, immunomodulation and thrombogenesis. Atherosclerosis. 2009;203(2):325–30.

Article  CAS  PubMed  Google Scholar 

White CM. A review of the pharmacologic and pharmacokinetic aspects of rosuvastatin. J Clin Pharmacol. 2002;42(9):963–70.

Article  CAS  PubMed  Google Scholar 

Agouridis AP, Kostapanos MS, Elisaf MS. Statins and their increased risk of inducing diabetes. Expert Opin Drug Saf. 2015;14(12):1835–44.

Article  CAS  PubMed  Google Scholar 

Sawada N, Liao JK. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal. 2014;20(8):1251–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Aiman U, Najmi A, Khan RA. Statin induced diabetes and its clinical implications. J Pharmacol Pharmacother. 2014;5(3):181.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brown JH, Del Re DP, Sussman MA. The Rac and Rho hall of fame. Circ Res. 2006;98(6):730–42.

Article  CAS  PubMed  Google Scholar 

Sawada N, Liao JK. Rho/Rho-associated coiled-coil forming kinase pathway as therapeutic targets for statins in atherosclerosis. Antioxid Redox Signal. 2014;20(8):1251–67.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kwok JM, Ma CCH, Ma S. Recent development in the effects of statins on cardiovascular disease through Rac1 and NADPH oxidase. Vascul Pharmacol. 2013;58(1):21–30.

Article  CAS  PubMed  Google Scholar 

Rashid M, Tawara S, Fukumoto Y, Seto M, Yano K, Shimokawa H. Importance of Rac1 signaling pathway inhibition in the pleiotropic effects of HMG-CoA reductase inhibitors. Circ J. 2009;73(2):361–70.

Article  CAS  PubMed  Google Scholar 

Babelova A, Jansen F, Sander K, Löhn M, Schäfer L, Fork C, et al. Activation of Rac-1 and RhoA contributes to podocyte injury in chronic kidney disease. PLoS ONE. 2013;8(11): e80328.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tanaka SI, Fukumoto Y, Nochioka K, Minami T, Kudo S, Shiba N, et al. Statins exert the pleiotropic effects through small GTP-binding protein dissociation stimulator upregulation with a resultant Rac1 degradation significance. Arterioscler Thromb Vasc Biol. 2013;33(7):1591–600.

Article  CAS  PubMed  Google Scholar 

Margaritis M, Sanna F, Antoniades C. Statins and oxidative stress in the cardiovascular system. Curr Pharm Des. 2017;23(46):7040–7.

Article  CAS  Google Scholar 

Den Hartog G, Chattopadhyay R, Ablack A, Hall EH, Butcher LD, Bhattacharyya A, et al. Regulation of Rac1 and reactive oxygen species production in response to infection of gastrointestinal epithelia. PLoS Pathog. 2016;12(1): e1005382.

Article  Google Scholar 

Shen E, Li Y, Li Y, Shan L, Zhu H, Feng Q, et al. Rac1 is required for cardiomyocyte apoptosis during hyperglycemia. Diabetes. 2009;58(10):2386–95.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jin S, Ray RM, Johnson LR. TNF-α/cycloheximide-induced apoptosis in intestinal epithelial cells requires Rac1-regulated reactive oxygen species. Am J Physiol Gastrointest Liver Physiol. 2008;294(4):928–37.

Article  Google Scholar 

Ota H, Eto M, Kano MR, Kahyo T, Setou M, Ogawa S, et al. Induction of endothelial nitric oxide synthase, Sirt1, and catalase by statins inhibits endothelial senescence through the AKT pathway. Arterioscler Thromb Vasc Biol. 2010;30(11):2205–11.

Article  CAS  PubMed  Google Scholar 

Maessen DE, Hanssen NM, Scheijen JL, van der Kallen CJ, van greevenbroek MM, Stehouwer CD, Schalkwijk CG. Post–glucose load plasma α-dicarbonyl concentrations are increased in individuals with impaired glucose metabolism and type 2 diabetes: the CODAM study. Diabetes Care. 2015;38(5):913–20.

Article  CAS  PubMed  Google Scholar 

Stitt AW. AGEs and diabetic retinopathy. Invest Ophthalmol Vis Sci. 2010;51(10):4867–74.

Article  PubMed  Google Scholar 

Maessen DE, Hanssen NM, Lips MA, Scheijen JL, van Dijk KW, Pijl H, et al. Energy restriction and Roux-en-Y gastric bypass reduce postprandial α-dicarbonyl stress in obese women with type 2 diabetes. Diabetologia. 2016;59(9):2013–7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Brouwers O, Niessen PM, Miyata T, Østergaard JA, Flyvbjerg A, Peutz-Kootstra CJ, et al. Glyoxalase-1 overexpression reduces endothelial dysfunction and attenuates early renal impairment in a rat model of diabetes. Diabetologia. 2014;57(1):224–35.

Article  CAS  PubMed  Google Scholar 

Chen HJC, Chen YC, Hsiao CF, Chen PF. Mass spectrometric analysis of glyoxal and methylglyoxal-induced modifications in human hemoglobin from poorly controlled type 2 diabetes mellitus patients. Chem Res Toxicol. 2015;28(12):2377–89.

Article  CAS  PubMed  Google Scholar 

Beisswenger PJ. Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications. Biochem Soc Trans. 2014;42(2):450–6.

Article  CAS  PubMed  Google Scholar 

Dornadula S, Elango B, Balashanmugam P, Palanisamy R, Kunka MR. Pathophysiological insights of methylglyoxal induced type-2 diabetes. Chem Res Toxicol. 2015;28(9):1666–74.

Article  CAS  PubMed  Google Scholar 

Tang W, Martin KA, Hwa J. Aldose reductase, oxidative stress and diabetic mellitus. Front Pharmacol. 2012;3:87.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Van Boekel MAJS. Formation of flavour compounds in the maillard reaction. Biotechnol Adv. 2006;24(2):230–3.

Article